CLTCL1
Basic information
Region (hg38): 22:19179473-19291719
Previous symbols: [ "CLTCL" ]
Links
Phenotypes
GenCC
Source:
- congenital insensitivity to pain with severe intellectual disability (Supportive), mode of inheritance: AR
- multiple congenital anomalies/dysmorphic syndrome (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLTCL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 20 | ||||
missense | 93 | 12 | 15 | 121 | ||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 2 | 6 | |||
non coding | 1 | |||||
Total | 0 | 1 | 97 | 27 | 24 |
Variants in CLTCL1
This is a list of pathogenic ClinVar variants found in the CLTCL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-19180764-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
22-19180775-C-T | Benign (Jul 01, 2024) | |||
22-19183415-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
22-19183443-C-G | Benign (Dec 31, 2019) | |||
22-19183443-C-T | Benign (Apr 19, 2019) | |||
22-19183471-C-T | CLTCL1-related disorder | Likely benign (Nov 08, 2023) | ||
22-19183486-AAGCAGGTCAT-A | Benign (Dec 31, 2019) | |||
22-19183518-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
22-19183540-C-G | not specified | Uncertain significance (Aug 04, 2022) | ||
22-19183561-C-CT | Likely benign (Dec 31, 2019) | |||
22-19183570-C-T | CLTCL1-related disorder | Likely benign (Feb 18, 2020) | ||
22-19183580-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
22-19187611-T-A | not specified | Uncertain significance (Feb 22, 2023) | ||
22-19187649-A-G | not specified | Uncertain significance (Nov 30, 2021) | ||
22-19187701-C-G | not specified | Uncertain significance (Jun 21, 2021) | ||
22-19187701-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
22-19187727-C-G | Likely benign (Nov 09, 2018) | |||
22-19187974-C-T | Likely benign (Nov 01, 2022) | |||
22-19188019-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
22-19188067-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
22-19188083-C-G | not specified | Uncertain significance (Nov 27, 2023) | ||
22-19188084-T-C | Uncertain significance (Sep 01, 2022) | |||
22-19191341-C-T | not specified | Uncertain significance (May 15, 2024) | ||
22-19191342-G-A | Uncertain significance (Sep 29, 2016) | |||
22-19191355-C-A | CLTCL1-related disorder | Likely benign (Feb 20, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLTCL1 | protein_coding | protein_coding | ENST00000263200 | 32 | 112254 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.51e-37 | 0.00333 | 1193 | 123631 | 13 | 124837 | 0.902 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.777 | 840 | 906 | 0.927 | 0.0000504 | 10770 |
Missense in Polyphen | 303 | 344.83 | 0.87869 | 4438 | ||
Synonymous | 0.765 | 336 | 354 | 0.948 | 0.0000205 | 3086 |
Loss of Function | 1.68 | 66 | 82.5 | 0.800 | 0.00000393 | 978 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 2.03 | 1.94 |
Ashkenazi Jewish | 1.01 | 0.919 |
East Asian | 1.00 | 0.958 |
Finnish | 1.00 | 0.956 |
European (Non-Finnish) | 1.00 | 0.872 |
Middle Eastern | 1.00 | 0.958 |
South Asian | 1.00 | 0.960 |
Other | 1.00 | 0.899 |
dbNSFP
Source:
- Function
- FUNCTION: Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Two different adapter protein complexes link the clathrin lattice either to the plasma membrane or to the trans-Golgi network (By similarity). {ECO:0000250}.;
- Pathway
- Synaptic vesicle cycle - Homo sapiens (human);Endocytosis - Homo sapiens (human);Lysosome - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human);Bacterial invasion of epithelial cells - Homo sapiens (human);Synaptic Vesicle Pathway;Vesicle-mediated transport;Membrane Trafficking;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Formation of annular gap junctions;Gap junction degradation;Gap junction trafficking;Gap junction trafficking and regulation
(Consensus)
Recessive Scores
- pRec
- 0.766
Intolerance Scores
- loftool
- 1.00
- rvis_EVS
- 2.35
- rvis_percentile_EVS
- 98.42
Haploinsufficiency Scores
- pHI
- 0.267
- hipred
- N
- hipred_score
- 0.219
- ghis
- 0.518
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.855
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- mitotic cell cycle;intracellular protein transport;receptor-mediated endocytosis;anatomical structure morphogenesis;retrograde transport, endosome to Golgi;positive regulation of glucose import;clathrin coat assembly;membrane organization
- Cellular component
- early endosome;late endosome;trans-Golgi network;spindle;cytosol;plasma membrane;clathrin-coated pit;membrane;clathrin coat of trans-Golgi network vesicle;coated vesicle;clathrin-coated vesicle;clathrin-coated endocytic vesicle;recycling endosome;extracellular exosome;clathrin complex;sorting endosome
- Molecular function
- structural molecule activity;protein binding;clathrin light chain binding